Inhalation Anesthetics Market To Surpass $2,144.6 Million Value by 2030, says P&S Intelligence

NEW YORK, July 21, 2022 /PRNewswire/ -- According to the latest market research report published by P&S Intelligence, in 2021, the inhalation anesthetics market was worth around $1,356.0 million, which is predicted to hit $2,144.6 million in the next 8 years, growing at a 5.2% CAGR from 2021 to 2030. This is because of the surging elderly population, which is prone to chronic ailments, growing trauma prevalence, and snowballing access to surgeries and other health services.

Key Market Insights

• Anesthetic drug manufacturers are in a fierce rivalry with one another, with the majority having already made generic versions of their products; additionally, price competition between them is severe.
• Inhalable anesthetics are frequently used for general anesthesia because life-saving medical operations, such as open-heart surgery, brain surgery, and organ transplantation, would not be feasible without complete sedation.
• Additionally, due to desflurane's low blood gas solubility, the inhalation anesthetics market revenue is predicted to escalate in the future. Moreover, due to its faster recovery time, the drug is frequently used to maintain general anesthesia during ambulatory procedures in patients over the age of 18.

Get the sample pages of this report at: https://www.psmarketresearch.com/market-analysis/inhalation-anesthetics-market/report-sample

North America Has Highest Demand for Inhalation Anesthetic Drugs

Geographically, the market is dominated by North America, which is mostly attributable to the improvements in anesthetic and surgical techniques, as well as the availability of new medicines in the region.

The APAC inhalation anesthetics market will grow at the highest CAGR in the coming years. The main causes of the surging use of anesthetic medications include the growing population, rising investments in healthcare infrastructure, increasing use of new technology in surgeries, and snowballing healthcare spending per person. 

Segmentation Analysis

With a share of 75.0%, sevoflurane dominates the market, and its usage, in terms of revenue generation, is predicted to grow at a compound annual growth rate of 5.1% in the coming years. This is because sevoflurane leads to rapid induction of anesthesia and quicker wear-off.

Browse detailed report on Inhalation Anesthetics Market Size, Share, Growth and Demand Forecast Report 2030

Additionally, during the forecast period, the need for isoflurane medications will grow at the highest rate. Isoflurane medications cost two-to-three times less than sevoflurane, which is why it is the favored general anesthesia agent in emerging economies, including Brazil, South Africa, India, and Indonesia.

Moreover, product sale to hospitals generates the majority of the inhalation anesthetics market revenue. Moreover, the hospitals category is predicted to advance at a CAGR of 5.6% in this decade. 

Major Companies in Inhalation Anesthetics Market: 

• Merck KGaA
• Jiangsu Hengrui Medicine Co. Ltd.
• Fresenius Kabi AG
• Sandoz International GmbH
• Lunan Pharmaceutical Group
• Halocarbon Products Corporation
• Hikma Pharmaceuticals PLC
• Piramal Enterprises Ltd.
• Abbvie Inc.
• Baxter International Inc.

Inhalation Anesthetics Market Report Coverage

By Drug Type

• Desflurane
• Sevoflurane
• Isoflurane

By End User

• Hospitals
• Ambulatory Surgical Centers

By Application

• Induction
• Maintenance

Regional Analysis

• North America
• U.S.
• Canada
• Europe
• France
• Germany
• Italy
• Spain
• U.K.
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Australia
• Latin America
• Brazil
• Mexico
• Middle East and Africa
• Saudi Arabia
• South Africa

Browse More Reports Published by P&S

Global Energy-Based Aesthetic Devices Market Size and Share Analysis, 2030

Global Particle Therapy Market Share and Growth Analysis Report, 2030

Global Radioligand Therapy Market Size, Share, and Demand Forecast to 2030

Global Surgical Robots Market Revenue Estimation and Demand Forecast to 2030

About P&S Intelligence

P&S Intelligence provides market research and consulting services to a vast array of industries across the world. As an enterprising research and consulting company, P&S believes in providing thorough insights on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness. P&S keeps the interest of its clients at heart, which is why the insights we provide are both honest and accurate. Our long list of satisfied clients includes entry-level firms as well as multi-million-dollar businesses and government agencies.

Contact: 
Prajneesh Kumar
P&S Intelligence
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com 
Web: https://www.psmarketresearch.com 
Follow Us: LinkedIn Twitter

Logo: https://mma.prnewswire.com/media/1224988/P_and_S_Intelligence_Logo.jpg